{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:03:39Z","timestamp":1793394219234,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.gtc.2010.12.003","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T04:46:38Z","timestamp":1298004398000},"page":"183-206","source":"Crossref","is-referenced-by-count":37,"title":["Centrally Acting Therapies for Irritable Bowel Syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Madhusudan","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Drossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib1","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","article-title":"AGA technical review on irritable bowel syndrome","volume":"123","author":"Drossman","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib2","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.gastro.2006.10.026","article-title":"Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders","volume":"131","author":"Mayer","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2010.12.003_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2982.2007.00965.x","article-title":"Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease","volume":"19","author":"Spiller","year":"2007","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2036.2006.03078.x","article-title":"Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease","volume":"24","author":"Mayer","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.gtc.2010.12.003_bib5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/gut.2004.048884","article-title":"Use of psychopharmacological agents for functional gastrointestinal disorders","volume":"54","author":"Clouse","year":"2005","journal-title":"Gut"},{"issue":"11\/12","key":"10.1016\/j.gtc.2010.12.003_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1365-2036.2004.02256.x","article-title":"The usual medical care for irritable bowel syndrome","volume":"20","author":"Whitehead","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2036.2008.03893.x","article-title":"Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database","volume":"29","author":"Canavan","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.gtc.2010.12.003_bib8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.18553\/jmcp.2008.14.9.870","article-title":"Self-reported use of pharmaceuticals among patients with irritable bowel syndrome in primary care","volume":"14","author":"Faresjo","year":"2008","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MCG.0b013e318189a7f9","article-title":"International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit","volume":"43","author":"Drossman","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2007.03.004","article-title":"Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints","volume":"5","author":"Camilleri","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-199805000-00007","article-title":"Presidential address: gastrointestinal illness and the biopsychosocial model","volume":"60","author":"Drossman","year":"1998","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/gast.2003.50024","article-title":"The \u201corganification\u201d of functional GI disorders: implications for research","volume":"124","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cgh.2008.08.032","article-title":"The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome","volume":"7","author":"Grover","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 8","key":"10.1016\/j.gtc.2010.12.003_bib14","first-page":"38","article-title":"Irritable bowel syndrome, anxiety, and depression: what are the links?","volume":"62","author":"Lydiard","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib15","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/gast.1996.v110.pm8613034","article-title":"Health status by gastrointestinal diagnosis and abuse history","volume":"110","author":"Drossman","year":"1996","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gtc.2010.12.003_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-123-10-199511150-00007","article-title":"Sexual and physical abuse and gastrointestinal illness: review and recommendations","volume":"123","author":"Drossman","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1572-0241.2000.01936.x","article-title":"What determines severity among patients with painful functional bowel disorders?","volume":"95","author":"Drossman","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2010.12.003_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/gut.2003.017962","article-title":"Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress","volume":"53","author":"Posserud","year":"2004","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/gut.44.3.306","article-title":"Mind over matter in the postinfective irritable bowel","volume":"44","author":"Drossman","year":"1999","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gtc.2010.12.003_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1542-3565(04)00350-7","article-title":"The presentation of irritable bowel syndrome in the context of somatization disorder","volume":"2","author":"North","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.2004.058446","article-title":"Brain imaging and its implications for studying centrally targeted treatments in IBS: a primer for gastroenterologists","volume":"54","author":"Drossman","year":"2005","journal-title":"Gut"},{"issue":"14","key":"10.1016\/j.gtc.2010.12.003_bib23","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3748\/wjg.v13.i14.2020","article-title":"Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment","volume":"13","author":"North","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-133-2-200007180-00013","article-title":"Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials","volume":"133","author":"Jailwala","year":"2000","journal-title":"Ann Intern Med"},{"issue":"11\u201312","key":"10.1016\/j.gtc.2010.12.003_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2036.2004.02267.x","article-title":"Meta-analysis: the treatment of irritable bowel syndrome","volume":"20","author":"Lesbros-Pantoflickova","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.1994.tb00308.x","article-title":"Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience","volume":"8","author":"Clouse","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1542-3565(03)70039-1","article-title":"The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study","volume":"1","author":"Kuiken","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2036.2004.02151.x","article-title":"Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception","volume":"20","author":"Siproudhis","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","article-title":"Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders","volume":"125","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","article-title":"The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome","volume":"124","author":"Creed","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2004.04127.x","article-title":"Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial","volume":"99","author":"Tabas","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PSY.0b013e31818d1e02","article-title":"Patients with pain disorder show gray-matter loss in pain-processing structures: a voxel-based morphometric study","volume":"71","author":"Valet","year":"2009","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib34","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1053\/j.gastro.2009.12.043","article-title":"Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors","volume":"138","author":"Blankstein","year":"2010","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gtc.2010.12.003_bib35","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A\u00a0systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9358","key":"10.1016\/j.gtc.2010.12.003_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gtc.2010.12.003_bib37","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/ajg.2009.341","article-title":"Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms","volume":"104","author":"Drossman","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1572-0241.2005.30375.x","article-title":"Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage","volume":"100","author":"Halpert","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2010.12.003_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2036.2005.02473.x","article-title":"New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline","volume":"21","author":"Otaka","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.2004.047423","article-title":"Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome","volume":"54","author":"Morgan","year":"2005","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.gtc.2010.12.003_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2036.2008.03633.x","article-title":"Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome","volume":"27","author":"Vahedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jpeds.2007.10.012","article-title":"Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents","volume":"152","author":"Bahar","year":"2008","journal-title":"J\u00a0Pediatr"},{"issue":"29","key":"10.1016\/j.gtc.2010.12.003_bib43","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3748\/wjg.15.3636","article-title":"A\u00a0randomized controlled trial of imipramine in patients with irritable bowel syndrome","volume":"15","author":"Abdul-Baki","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.gtc.2010.12.003_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(98)00031-1","article-title":"Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon","volume":"76","author":"Su","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.gastro.2003.11.047","article-title":"The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor","volume":"126","author":"Willert","year":"2004","journal-title":"Gastroenterology"},{"issue":"3 Pt 1","key":"10.1016\/j.gtc.2010.12.003_bib47","first-page":"G460","article-title":"Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans","volume":"275","author":"Gorelick","year":"1998","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2982.2007.01029.x","article-title":"The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial","volume":"20","author":"Choung","year":"2008","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2036.2008.03918.x","article-title":"Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome","volume":"29","author":"Thoua","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/gast.2003.50103","article-title":"Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome","volume":"124","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2007.11.011","article-title":"Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study","volume":"134","author":"Ringel","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1994.tb00273.x","article-title":"Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome","volume":"8","author":"Gorard","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","article-title":"The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study","volume":"22","author":"Vahedi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.gtc.2010.12.003_bib54","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gut.2005.077503","article-title":"A\u00a0controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome","volume":"55","author":"Tack","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10620-007-9830-4","article-title":"Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial","volume":"53","author":"Talley","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.psy.50.1.78","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome","volume":"50","author":"Masand","year":"2009","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2009.09.008","article-title":"Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome","volume":"8","author":"Ladabaum","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2010.12.003_bib58","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/gut.2005.086348","article-title":"How do SSRIs help patients with irritable bowel syndrome?","volume":"55","author":"Creed","year":"2006","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hup.1038","article-title":"Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study","volume":"24","author":"Brennan","year":"2009","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib60","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00045391-200309000-00003","article-title":"Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder","volume":"10","author":"Bradley","year":"2003","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib61","doi-asserted-by":"crossref","first-page":"G130","DOI":"10.1152\/ajpgi.00266.2002","article-title":"Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health","volume":"284","author":"Chial","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1016\/j.gtc.2010.12.003_bib62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","article-title":"Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"van Kerkhoven","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1542-3565(03)70038-X","article-title":"Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans","volume":"1","author":"Chial","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1526-4637.2004.04054.x","article-title":"Do the second-generation \u201catypical neuroleptics\u201d have analgesic properties? A structured evidence-based review","volume":"5","author":"Fishbain","year":"2004","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy","volume":"23","author":"Hamner","year":"2003","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib66","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10620-009-0723-6","article-title":"Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders","volume":"54","author":"Grover","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0885-3924(02)00391-3","article-title":"A\u00a0pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain","volume":"23","author":"Passik","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1037\/0022-006X.62.3.576","article-title":"Cognitive therapy for irritable bowel syndrome","volume":"62","author":"Greene","year":"1994","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib69","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1037\/0022-006X.63.5.779","article-title":"A\u00a0controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome","volume":"63","author":"Payne","year":"1995","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.gtc.2010.12.003_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0005-7894(98)80016-6","article-title":"Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome","volume":"29","author":"Vollmer","year":"1998","journal-title":"Behav Ther"},{"key":"10.1016\/j.gtc.2010.12.003_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1022809914863","article-title":"Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting","volume":"10","author":"Tkachuk","year":"2003","journal-title":"J\u00a0Clin Psychol Med Settings"},{"issue":"19","key":"10.1016\/j.gtc.2010.12.003_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10190","article-title":"Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial","volume":"10","author":"Kennedy","year":"2006","journal-title":"Health Technol Assess"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.brat.2006.07.003","article-title":"A\u00a0controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome","volume":"45","author":"Blanchard","year":"2007","journal-title":"Behav Res Ther"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10484-007-9037-7","article-title":"Preliminary study of a self-administered treatment for irritable bowel syndrome: comparison to a wait list control group","volume":"32","author":"Sanders","year":"2007","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"8","key":"10.1016\/j.gtc.2010.12.003_bib75","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2008.03.004","article-title":"Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility","volume":"6","author":"Lackner","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2010.12.003_bib76","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.brat.2009.05.002","article-title":"Brief cognitive-behavioral Internet therapy for irritable bowel syndrome","volume":"47","author":"Hunt","year":"2009","journal-title":"Behav Res Ther"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0033291709990195","article-title":"A\u00a0randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care","volume":"40","author":"Moss-Morris","year":"2010","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib78","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cgh.2010.02.007","article-title":"Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome","volume":"8","author":"Lackner","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpsychores.2010.01.003","article-title":"Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care","volume":"68","author":"Reme","year":"2010","journal-title":"J\u00a0Psychosom Res"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib80","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.gastro.2007.05.014","article-title":"How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial","volume":"133","author":"Lackner","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib81","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.brat.2005.05.002","article-title":"Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety","volume":"44","author":"Lackner","year":"2006","journal-title":"Behav Res Ther"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00999789","article-title":"Relaxation training as a treatment for irritable bowel syndrome","volume":"18","author":"Blanchard","year":"1993","journal-title":"Biofeedback Self Regul"},{"issue":"7","key":"10.1016\/j.gtc.2010.12.003_bib83","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0005-7967(00)00078-4","article-title":"The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study","volume":"39","author":"Keefer","year":"2001","journal-title":"Behav Res Ther"},{"issue":"10","key":"10.1016\/j.gtc.2010.12.003_bib84","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1572-0241.2003.07716.x","article-title":"A\u00a0randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome","volume":"98","author":"Boyce","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib85","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2007.03437.x","article-title":"Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome","volume":"26","author":"van der Veek","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/acm.2009.0084","article-title":"Functional relaxation as complementary therapy in irritable bowel syndrome: a randomized, controlled clinical trial","volume":"16","author":"Lahmann","year":"2010","journal-title":"J\u00a0Altern Complement Med"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1752-0118.2001.tb00006.x","article-title":"Use of farewell letters in the context of brief psychodynamic-interpersonal therapy with irritable bowel syndrome patients","volume":"18","author":"Howlett","year":"2001","journal-title":"Br J Psychother"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0016-5085(91)90215-7","article-title":"A\u00a0controlled trial of psychological treatment for the irritable bowel syndrome","volume":"100","author":"Guthrie","year":"1991","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib89","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","article-title":"A\u00a0randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia","volume":"119","author":"Hamilton","year":"2000","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.gtc.2010.12.003_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pain.2009.07.005","article-title":"Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome","volume":"145","author":"Hyphantis","year":"2009","journal-title":"Pain"},{"issue":"8414","key":"10.1016\/j.gtc.2010.12.003_bib91","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(84)92793-4","article-title":"Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome","volume":"2","author":"Whorwell","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gtc.2010.12.003_bib92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00207140500328708","article-title":"Hypnosis for irritable bowel syndrome: the empirical evidence of therapeutic effects","volume":"54","author":"Whitehead","year":"2006","journal-title":"Int J Clin Exp Hypn"},{"issue":"11","key":"10.1016\/j.gtc.2010.12.003_bib93","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/gut.52.11.1623","article-title":"Long term benefits of hypnotherapy for irritable bowel syndrome","volume":"52","author":"Gonsalkorale","year":"2003","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib94","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","article-title":"Long-term improvement in functional dyspepsia using hypnotherapy","volume":"123","author":"Calvert","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2010.12.003_bib95","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1572-0241.2002.05615.x","article-title":"Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness","volume":"97","author":"Gonsalkorale","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2010.12.003_bib96","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2036.2003.01486.x","article-title":"Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome","volume":"17","author":"Lea","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.gtc.2010.12.003_bib97","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1023\/A:1020545017390","article-title":"Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms","volume":"47","author":"Palsson","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3999(03)00076-X","article-title":"Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome","volume":"56","author":"Gonsalkorale","year":"2004","journal-title":"J\u00a0Psychosom Res"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib99","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jbtep.2010.01.001","article-title":"Exposure and mindfulness based therapy for irritable bowel syndrome\u2014an open pilot study","volume":"41","author":"Ljotsson","year":"2010","journal-title":"J\u00a0Behav Ther Exp Psychiatry"},{"key":"10.1016\/j.gtc.2010.12.003_bib100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6882-9-24","article-title":"Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial","volume":"9","author":"Gaylord","year":"2009","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0005-7967(92)90141-3","article-title":"Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome","volume":"30","author":"Blanchard","year":"1992","journal-title":"Behav Res Ther"},{"issue":"7","key":"10.1016\/j.gtc.2010.12.003_bib102","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1542-3565(04)00242-3","article-title":"Self-management for women with irritable bowel syndrome","volume":"2","author":"Heitkemper","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2010.12.003_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01003478","article-title":"Behavioral treatment of irritable bowel syndrome: a 1-year follow-up study","volume":"11","author":"Schwarz","year":"1986","journal-title":"Biofeedback Self Regul"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/0003-4819-122-2-199501150-00005","article-title":"The irritable bowel syndrome: long-term prognosis and the physician-patient interaction","volume":"122","author":"Owens","year":"1995","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2010.12.003_bib105","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/00004836-200207001-00010","article-title":"Psychotropic agents in irritable bowel syndrome","volume":"35","author":"Wald","year":"2002","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"12","key":"10.1016\/j.gtc.2010.12.003_bib106","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1023\/A:1026645914933","article-title":"Long-term outcome from tricyclic antidepressant treatment of functional chest pain","volume":"44","author":"Prakash","year":"1999","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.gtc.2010.12.003_bib107","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PSY.0b013e318031391d","article-title":"Predictors of premature antidepressant discontinuation in functional gastrointestinal disorders","volume":"69","author":"Sayuk","year":"2007","journal-title":"Psychosom Med"},{"issue":"6","key":"10.1016\/j.gtc.2010.12.003_bib108","first-page":"336","article-title":"Optimizing patient care: the psychosocial interview in the irritable bowel syndrome","volume":"5","author":"Chang","year":"2002","journal-title":"Clin Perspect Gastroenterol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855310001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855310001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T13:56:42Z","timestamp":1543931802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855310001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0889855310001275"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2010.12.003","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}